Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma

Simple item page
dc.contributor.authorMoitra, Subhabrata
dc.date.accessioned2026-08-18T20:44:27Z
dc.date.issued2026-07
dc.description.abstract[No abstract available]
dc.identifier.citationMarriott, H., Adatia, A., Moitra, Subhabrata, & Lacy, P. (2026). Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma. Clinical and Experimental Allergy, 56(7), 830–832. Scopus. https://doi.org/10.1111/cea.70294
dc.identifier.doihttps://onlinelibrary.wiley.com/doi/10.1111/cea.70294
dc.identifier.issn0954-7894E
dc.identifier.issn1365-2222
dc.identifier.urihttps://ir.ahduni.edu.in/handle/123456789/8000
dc.language.isoen
dc.publisherWiley-Blackwell Publishing Ltd
dc.schoolBagchi School of Public Health
dc.sourceClinical and Experimental Allergy
dc.subjectAlarmin
dc.subjectCytokine
dc.subjectTezepelumab
dc.subjectAdult
dc.subjectAirway epithelium cell
dc.titleTezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma
dc.typeJournal Article

Files

Collections

Journal Articles